Jinmei Jin

1.3k total citations
38 papers, 988 citations indexed

About

Jinmei Jin is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jinmei Jin has authored 38 papers receiving a total of 988 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Immunology. Recurrent topics in Jinmei Jin's work include Protein Degradation and Inhibitors (7 papers), Peptidase Inhibition and Analysis (6 papers) and Ginseng Biological Effects and Applications (5 papers). Jinmei Jin is often cited by papers focused on Protein Degradation and Inhibitors (7 papers), Peptidase Inhibition and Analysis (6 papers) and Ginseng Biological Effects and Applications (5 papers). Jinmei Jin collaborates with scholars based in China, United States and Russia. Jinmei Jin's co-authors include Xin Luan, Hongzhuan Chen, Ye Wu, Lijun Zhang, Hui Wu, Hailian Shi, Fei Huang, Xiaojun Wu, Weidong Zhang and Hong Zhang and has published in prestigious journals such as Journal of Medicinal Chemistry, Biochemical Pharmacology and Advanced Science.

In The Last Decade

Jinmei Jin

35 papers receiving 979 citations

Peers

Jinmei Jin
Comparison fields: 5 of 97
  • Molecular Biology 584
  • Oncology 232
  • Cancer Research 132
  • Immunology 121
  • Pharmacology 104
Replace Yuan‐Zheng Xia with:
Yuan‐Zheng Xia China
Ming Yue Li China
Chunliu Mi China
Maolun Liu China
Xuejun Jin China
Xi Zou China
Wenyu Wu China
Bilal Rah India
Yuan‐Zheng Xia China View profile →
Citations per field, relative to Jinmei Jin
Jinmei Jin · 1×
Citations per year, relative to Jinmei Jin
Jinmei Jin · 1×

Countries citing papers authored by Jinmei Jin

Since Specialization
Citations

This map shows the geographic impact of Jinmei Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinmei Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinmei Jin more than expected).

Fields of papers citing papers by Jinmei Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinmei Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinmei Jin. The network helps show where Jinmei Jin may publish in the future.

Co-authorship network of co-authors of Jinmei Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Jinmei Jin. A scholar is included among the top collaborators of Jinmei Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinmei Jin. Jinmei Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 1
3 0
4 7
5 11
6 21
7 41
8 25
9 30
10 51
11 19
12 37
13 61
14 21
15 23
16 100
17 174
18 107
19 36
20
Study on the Effect of Panaxatriol on the Sensitivity of Chemical Medicine to Leukemia Cells
0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026